Hyung Seok Kim
he/him/his
Visiting Research ScientistCards
About
Research
Publications
2025
Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression
Kim H, Choi J, Jang S, Kang M, Yoon M, Baek G, Park W, Han J, Cho H, Jeong J, Cheong J, Kim S, Eun J. Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression. Scientific Reports 2025, 15: 42459. PMID: 41309856, PMCID: PMC12660675, DOI: 10.1038/s41598-025-26639-0.Peer-Reviewed Original ResearchA Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma
Kim H, Choi J, Baek G, Yoon M, Jang S, Han J, Kim S, Cheong J, Jeong J, Eun J. A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma. Frontiers In Bioscience-Landmark 2025, 30: 41684. PMID: 40765359, DOI: 10.31083/fbl41684.Peer-Reviewed Original ResearchCTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications
Kim H, Jang H, Baek G, Yoon M, Shim J, Han J, Kim S, Cheong J, Eun J. CTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications. Current Issues In Molecular Biology 2025, 47: 563. PMID: 40729031, PMCID: PMC12293479, DOI: 10.3390/cimb47070563.Peer-Reviewed Original ResearchA Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI-eIF2α-ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies.
Kim M, Kwak J, Kim H, Han J, Kang J, Jo J, Kim J, Kim D, Lee H, Yun H, Jeong J. A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI-eIF2α-ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies. Molecular Cancer Therapeutics 2025, 24: 1546-1560. PMID: 40293252, DOI: 10.1158/1535-7163.mct-24-0998.Peer-Reviewed Original ResearchCorrespondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”
Kim S, Kim H, Cheong J, Eun J. Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”. Clinical And Molecular Hepatology 2025, 32: e72-e74. PMID: 40181674, PMCID: PMC12835751, DOI: 10.3350/cmh.2025.0350.Peer-Reviewed Original ResearchCorrespondence: Response to the Letter Regarding
Kim H, Kim S, Cheong J, Eun J. Correspondence: Response to the Letter Regarding. Clinical And Molecular Hepatology 2025, 32: e103-e105. PMID: 40107309, PMCID: PMC12835742, DOI: 10.3350/cmh.2025.0287.Commentaries, Editorials and LettersGULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma
Kim H, Yoon J, Choi J, Yoon M, Baek G, Kang M, Jang H, Park W, Go Y, Ng J, Nam S, Jeong J, Han J, Cho H, Bin Lim S, Kim S, Cheong J, Eun J. GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma. Clinical And Molecular Hepatology 2025, 31: 914-934. PMID: 39914372, PMCID: PMC12260647, DOI: 10.3350/cmh.2024.1038.Peer-Reviewed Original ResearchAdaptor Proteins, Signal TransducingADP-Ribosylation Factorsalpha-FetoproteinsAnimalsbeta CateninBiomarkers, TumorCarcinoma, HepatocellularCell Line, TumorCell ProliferationEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMaleMiceMiddle AgedNeoplasm Recurrence, LocalPrognosisGlycoRNA: A new player in cellular communication
KIM H. GlycoRNA: A new player in cellular communication. Oncology Research Featuring Preclinical And Clinical Cancer Therapeutics 2025, 33: 995-1000. PMID: 40296915, PMCID: PMC12034019, DOI: 10.32604/or.2025.060616.Peer-Reviewed Original Research
2024
The diverse landscape of RNA modifications in cancer development and progression
Kim H, Eun J, Jang S, Kim J, Jeong J. The diverse landscape of RNA modifications in cancer development and progression. Genes & Genomics 2024, 47: 135-155. PMID: 39643826, DOI: 10.1007/s13258-024-01601-y.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2023
A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers
Eun J, Cheong J, Jeong J, Kim H. A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers. Cells 2023, 12: 2272. PMID: 37759495, PMCID: PMC10528438, DOI: 10.3390/cells12182272.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Get In Touch
Contacts
Mailing Address
Yale Cancer Center
300 George Street , Rm786
New Haven, CT 06511
United States